Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?

Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?

01 Dec 2022 11:07 AM | Anonymous

Sihag, Smita MD*; Nobel, Tamar MD*; Hsu, Meier MS†; De La Torre, Sergio*; Tan, Kay See PhD†; Janjigian, Yelena Y. MD‡; Ku, Geoffrey Y. MD‡; Tang, Laura H. MD, PhD§; Wu, Abraham J. MD∥; Maron, Steven B. MD‡; Bains, Manjit S. MD*; Jones, David R. MD*; Molena, Daniela MD*

Read Abstract: Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software